APVO - CIK 0001671584
Aptevo Therapeutics Inc. has filed 690 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (221 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2021-08-17 | 2021-08-17 |
| SEC correspondence | UPLOAD | 2021-08-17 | - |
| Securities registration | S-3 | 2021-08-12 | - |
| Major company event | 8-K | 2021-08-12 | 2021-08-12 |
| Quarterly report | 10-Q | 2021-08-12 | 2021-06-30 |
| Major company event | 8-K | 2021-06-28 | 2021-06-25 |
| Activist ownership stake (update) | SC 13D/A | 2021-06-21 | - |
| Proxy materials | DEFA14A | 2021-06-21 | - |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| Insider trade | 4 | 2021-06-02 | 2021-06-01 |
| New insider ownership | 3 | 2021-06-02 | 2021-05-24 |
| Major company event | 8-K | 2021-05-27 | 2021-05-27 |
| Major company event | 8-K | 2021-05-26 | 2021-05-26 |
| DEFC14A | - | 2021-05-11 | - |
| Quarterly report | 10-Q | 2021-05-11 | 2021-03-31 |
| Major company event | 8-K | 2021-05-11 | 2021-05-11 |
| Company correspondence | CORRESP | 2021-05-05 | - |
| SEC correspondence | UPLOAD | 2021-05-04 | - |
| PREC14A | - | 2021-04-28 | - |
| Annual report (amended) | 10-K/A | 2021-04-28 | 2020-12-31 |
| Proxy materials | DEFA14A | 2021-03-31 | - |
| Proxy materials | DEFA14A | 2021-03-31 | - |
| Major company event | 8-K | 2021-03-31 | 2021-03-30 |
| Annual report | 10-K | 2021-03-31 | 2020-12-31 |
| Insider trade | 4 | 2021-02-17 | 2021-01-29 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Insider trade | 4 | 2021-02-17 | 2021-01-29 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Insider trade | 4 | 2021-02-17 | 2021-01-29 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Insider trade | 4 | 2021-02-17 | 2020-07-02 |
| Passive ownership stake (update) | SC 13G/A | 2021-02-16 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-02-16 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-02-12 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-02-12 | - |
| Passive ownership stake (update) | SC 13G/A | 2021-02-11 | - |
| Proxy materials | DEFA14A | 2021-02-10 | - |
| DFAN14A | - | 2021-02-09 | - |
| Activist ownership stake (update) | SC 13D/A | 2021-02-09 | - |
| EFFECT | - | 2020-12-18 | - |
| Company correspondence | CORRESP | 2020-12-17 | - |
| SEC correspondence | UPLOAD | 2020-12-17 | - |
| Major company event | 8-K | 2020-12-14 | 2020-12-14 |